Welcome to The Visible Embryo
Home-- -History-- -Bibliography- -Pregnancy Timeline- --Prescription Drugs in Pregnancy- -- Pregnancy Calculator- --Female Reproductive System- -Contact
 

Welcome to The Visible Embryo, a comprehensive educational resource on human development from conception to birth.

The Visible Embryo provides visual references for changes in fetal development throughout pregnancy and can be navigated via fetal development or maternal changes.

The National Institutes of Child Health and Human Development awarded Phase I and Phase II Small Business Innovative Research Grants to develop The Visible Embryo. Initally designed to evaluate the internet as a teaching tool for first year medical students, The Visible Embryo is linked to over 600 educational institutions and is viewed by more than one million visitors each month.

Today, The Visible Embryo is linked to over 600 educational institutions and is viewed by more than 1 million visitors each month. The field of early embryology has grown to include the identification of the stem cell as not only critical to organogenesis in the embryo, but equally critical to organ function and repair in the adult human. The identification and understanding of genetic malfunction, inflammatory responses, and the progression in chronic disease, begins with a grounding in primary cellular and systemic functions manifested in the study of the early embryo.

WHO International Clinical Trials Registry Platform


The World Health Organization (WHO) has created a new Web site to help researchers, doctors and
patients obtain reliable information on high-quality clinical trials. Now you can go to one website and search all registers to identify clinical trial research underway around the world!



Home

History

Bibliography

Pregnancy Timeline

Prescription Drug Effects on Pregnancy

Pregnancy Calculator

Female Reproductive System

Contact The Visible Embryo

News Alerts Archive

Disclaimer: The Visible Embryo web site is provided for your general information only. The information contained on this site should not be treated as a substitute for medical, legal or other professional advice. Neither is The Visible Embryo responsible or liable for the contents of any websites of third parties which are listed on this site.
Content protected under a Creative Commons License.

No dirivative works may be made or used for commercial purposes.

 

Pregnancy Timeline by SemestersFetal liver is producing blood cellsHead may position into pelvisBrain convolutions beginFull TermWhite fat begins to be madeWhite fat begins to be madeHead may position into pelvisImmune system beginningImmune system beginningPeriod of rapid brain growthBrain convolutions beginLungs begin to produce surfactantSensory brain waves begin to activateSensory brain waves begin to activateInner Ear Bones HardenBone marrow starts making blood cellsBone marrow starts making blood cellsBrown fat surrounds lymphatic systemFetal sexual organs visibleFinger and toe prints appearFinger and toe prints appearHeartbeat can be detectedHeartbeat can be detectedBasic Brain Structure in PlaceThe Appearance of SomitesFirst Detectable Brain WavesA Four Chambered HeartBeginning Cerebral HemispheresFemale Reproductive SystemEnd of Embryonic PeriodEnd of Embryonic PeriodFirst Thin Layer of Skin AppearsThird TrimesterSecond TrimesterFirst TrimesterFertilizationDevelopmental Timeline
CLICK ON weeks 0 - 40 and follow along every 2 weeks of fetal development
Google Search artcles published since 2007
 
 

Home | Pregnancy Timeline | News Alerts |News Archive Nov 10, 2014

Structures of the hypothalamus and the pituitary gland in the human brain produce these hormones.

 









 

 

Sugars help us differentiate seasons

Scientists have discovered how a single hormone manages to trigger two different physiologic functions — the sensing of season changes and functional metabolism, without any mixup.

Extensive national and international collaboration between ITbM, Nagoya University, and the University of Chicago has uncovered how thyrotropin, a thyroid stimulating hormone (TSH), triggers two different functions when released into the bloodstream, yet manages to avoid crosstalk.

TSH is a glycoprotein — a protein that contains carbohydrate — and is secreted from two parts of the brain's pituitary gland: the stalk of the pituitary gland called the pars tuberalis; and from the front of the pituitary gland called the pars distalis.

Previous studies have shown that TSHs secreted from both of these regions have the same protein structure. However, TSH secreted from the pars distalis stimulates thyroid to secrete thyroid hormones regulating metabolism and growth, while Yoshimura's group found that TSH secreted from the pars tuberalis acts on the hypothalamus to send information on seasonal change.

It had been a mystery how these two TSHs manage to distinctively trigger biologically significant processes without interfering with one another. However, a study published on October 30, 2014 in Cell Reports, revealed that the same molecule imparts different functions without cross activity by using tissue-specific glycosylation — attaching sugars — which assist recognition by the immune system. This new paradigm is expected to contribute towards our understanding of diseases related to the synthesis and secretion of TSHs.


Many organisms adapt to seasonal changes by detecting changes in the amount of sunlight.


Observed with mass spectrometry analysis, both PT-TSH and PD-TSH share the same protein structure. But each has a different carbohydrate chain attached that distinguishes them: PD-TSH has sulfated bi-antennary carbohydrate chains, which are easily metabolized; and PT-TSH has sialylated multi-branched carbohydrate chains, that stabilize macro-TSH complexes and therefore do not stimulate the thyroid.

Although the fundamental importance of glycosylation has been recognized in recent years, its physiologic function had remained unclear. This study illustrates the first tissue-specific glycosylation that prevents crosstalk between signaling molecules.

Prof. Yoshimura : "As the genome is finite, organisms use the same protein to serve multiple functions. Through our research, we were able to uncover the elegant strategy of tissue-specific glycosylation to impart 2 distinctive functions on a single hormone."

Highlights

•Tissue-specific glycosylation imparts specificity to thyroid-stimulating hormone

•Pars tuberalis-TSH (PT-TSH) does not stimulate the thyroid gland

•PT-TSH has tissue-specific N-glycans and forms macro-TSH in blood

•Macro-TSH circulating in blood does not stimulate thyroid hormone secretion

Summary
Thyroid-stimulating hormone (TSH; thyrotropin) is a glycoprotein secreted from the pituitary gland. Pars distalis-derived TSH (PD-TSH) stimulates the thyroid gland to produce thyroid hormones (THs), whereas pars tuberalis-derived TSH (PT-TSH) acts on the hypothalamus to regulate seasonal physiology and behavior. However, it had not been clear how these two TSHs avoid functional crosstalk. Here, we show that this regulation is mediated by tissue-specific glycosylation. Although PT-TSH is released into the circulation, it does not stimulate the thyroid gland. PD-TSH is known to have sulfated biantennary N-glycans, and sulfated TSH is rapidly metabolized in the liver. In contrast, PT-TSH has sialylated multibranched N-glycans; in the circulation, it forms the macro-TSH complex with immunoglobulin or albumin, resulting in the loss of its bioactivity. Glycosylation is fundamental to a wide range of biological processes. This report demonstrates its involvement in preventing functional crosstalk of signaling molecules in the body.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).

Professor Takashi Yoshimura and Dr. Keisuke Ikegami (currently at Kinki University) at the Institute of Transformative Bio-Molecules (ITbM) of Nagoya University, Prof. Samuel Refetoff of the University of Chicago

Authors
This article "Tissue-specific post-translational modification allows functional targeting of thyrotropin" by Keisuke Ikegami, Xiao-Hui Liao, Yuta Hoshino, Hiroko Ono, Wataru Ota, Yuka Ito, Taeko Nishiwaki-Ohkawa, Chihiro Sato, Ken Kitajima, Masayuki Iigo, Yasufumi Shigeyoshi, Masanobu Yamada, Yoshiharu Murata, Samuel Refetoff, Takashi Yoshimura is published online on October 30, 2014 in Cell Reports.

DOI: 10.1016/j.celrep.2014.10.006

About WPI-ITbM
The World Premier International Research Center Initiative (WPI) for the Institute of Transformative Bio-Molecules (ITbM) at Nagoya University in Japan is committed to advance the integration of synthetic chemistry, plant/animal biology and theoretical science, all of which are traditionally strong fields in the university. As part of the Japanese science ministry's MEXT program, ITbM aims to develop transformative bio-molecules, innovative functional molecules capable of bringing about fundamental change to biological science and technology. Research at ITbM is carried out in a "Mix-Lab" style, where international young researchers from multidisciplinary fields work together side-by-side in the same lab. Through these endeavors, ITbM will create "transformative bio-molecules" that will dramatically change the way of research in chemistry, biology and other related fields to solve urgent problems, such as environmental issues, food production and medical technology that have a significant impact on society.


Return to top of page